IRS Financing Cash Flow

IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of Common Stock) · Financing Cash Flow

IRS logo

IRS Financing Cash Flow

Latest reported-$22.68B ARS
IRS TTM Cash from Financing · ARS ($96.66M → -$22.68B)
High-resolution chart · PNG

IRS financing cash flow history

Trailing twelve months (TTM) · ARS. Each value covers four complete reported quarters.

IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of Common Stock) Financing Cash Flow — Trailing twelve months (TTM) (ARS)
Period endingFinancing Cash Flow (ARS)
-22,679,206,074
-56,229,939,006
169,321,463
70,802,289
80,881,530
-20,526,001,538
190,502,737,993
157,911,420,326
130,318,000,000
130,318,000,000
-149,774,000,000
-155,275,000,000
-171,567,000,000
-151,120,000,000
-97,781,000,000
-69,648,000,000
-27,635,000,000
-12,516,000,000
-1,812,000,000
-9,344,000,000
-48,840,000,000
-74,025,000,000
-72,686,000,000
-82,273,000,000
-76,125,000,000
-72,981,000,000
-88,925,000,000
-76,885,000,000
-25,324,000,000
-27,078,000,000
-12,989,000,000
12,547,000,000
237,000,000
10,065,000,000
13,851,000,000
5,311,000,000
1,537,000,000
-3,900,000,000
-2,486,000,000
-3,943,000,000
-3,968,000,000
490,874,000
271,874,000
-465,774,000
-1,390,126,000
-1,206,272,000
-1,165,164,000
-1,061,930,000
-596,767,000
-823,040,000
-644,630,000
-398,698,000
-306,268,000
-358,702,000
-303,112,000
-596,170,000
-513,243,000
-594,692,000
-614,852,000
-23,619,000
331,180,000
672,550,000
855,335,000
455,915,000
145,711,000
17,911,000
-108,148,000
-116,783,000
-58,898,000
111,197,195
146,857,035
27,793,079
110,434,194
423,876,603
707,012,144
1,013,288,459
871,929,664
468,330,110
179,300,107
-13,125,378
2,303,525
-15,673,358
7,283,258
44,998,141
52,844,577
40,845,875
-6,662,180
-18,096,142
-47,811,103
-40,038,040
-54,355,020
103,828,105
109,979,214
68,231,681
96,660,722
-66,228,198
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.